New advances in cancer therapy targeting TGF-β signaling pathways

Minyue Shou, Hanyu Zhou, Ling Ma · 2023

Read New advances in cancer therapy targeting TGF-β signaling pathways by Minyue Shou, Hanyu Zhou, Ling Ma (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10746361.txt.

Description

Minyue Shou, Hanyu Zhou, and Ling Ma review in this 2023 paper new cancer therapies that target the TGF-beta pathway. Tumors pour out this signal to mute the immune attack, and high levels track with poor outlook in many cancers. The review gives pride of place to a recent design: decoy receptors, built from the signal's own receptor, anchored to engineered T cells so they soak the signal up.

T cells with the decoy kept making attack signals and drained TGF-beta from their surroundings in lab work. The authors also survey other ways to block the path and the blocks that slow the field: the signal's dual role, toxicity risks, and thin dosing data. In-vivo proof for the decoy is still owed.

Catalog record

CREATORMinyue Shou, Hanyu Zhou, Ling Ma
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10746361

Browse the full library · About the Tower of Babel